4//SEC Filing
XBiotech Inc. 4
Accession 0001209191-17-041608
$XBITCIK 0001626878operating
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 2:15 PM ET
Size
9.6 KB
Accession
0001209191-17-041608
Insider Transaction Report
Form 4
XBiotech Inc.XBIT
SHIVASWAMY SUSHMA
VP of R&D
Transactions
- Exercise/Conversion
Stock Option
2017-06-19$4.24/sh+50,000$212,000→ 50,000 totalExercise: $4.24From: 2018-06-19Exp: 2027-06-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]On September 14, 2016 (the Grant Date) Fabrizio Bonanni was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market, with an expiry of ten years from the Grant Date. Half of the Options vest on December 20, 2016 and another half of the Options vest on June 20, 2017.
Issuer
XBiotech Inc.
CIK 0001626878
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001626878
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 2:15 PM ET
- Size
- 9.6 KB